AI-powered healthcare intelligence company Komodo Health has announced the launch of Marmot™—a healthcare-native AI engine that uses healthcare analytics and real-world data to provide actionable insights to Life Sciences and healthcare teams within minutes. This greatly improves the speed at which these teams are able to make important decisions in medical care and research, increasing the potential for innovation and the development of life-saving treatments and therapies.
Arif Nathoo, MD, CEO and co-founder of Komodo Health, explained the importance that Marmot holds in the current healthcare landscape, stating, “With healthcare reasoning and pharmaceutical domain expertise engineered directly into the AI, Marmot fundamentally enhances analytical velocity, transforming complex questions that previously took weeks to answer into strategic, evidence-based insights in minutes. By designing Marmot to handle the complex analytical work, [Komodo Health is] creating space for Life Sciences teams to focus on strategic decisions that bring therapies to patients faster.”
Komodo Health President and co-founder Web Sun also expressed the incredible potential that Marmot brings to the healthcare market, saying, “Marmot demonstrates what’s possible when AI is built specifically for pharmaceutical insights workflows rather than retrofitted from generic consumer applications. By integrating seamlessly across Commercial and Medical Affairs operations while meeting the rigorous transparency and auditability standards that regulated industries require, Marmot doesn’t just deliver faster analytics, it gives Life Sciences teams the confidence to act on AI-generated insights.”
Founded in 2014 by Arif Nathoo and Web Sun, Komodo Health operates with over 700 employees out of San Francisco, California, and strives to improve patient care and reduce disease burdens through the use of real-world data-driven insights. To learn more about this announcement, view the Komodo Health press release below.
See related materials: